The Proteomics of Precision – with Jennifer Van Eyk
Ahead of ISC2026 in Prague, Jennifer Van Eyk explains how scalable LC-MS workflows and single-cell proteomics are helping reveal the biological differences that could make precision medicine a clinical reality
By
James Strachan
Frank van Geel
June 17, 2026
Clinical Scorecard: The Proteomics of Precision – with Jennifer Van Eyk
At a Glance
Category Detail
Condition Women’s heart health Key Mechanisms Single-cell proteomics and LC-MS workflows Target Population Individuals with cardiac diseases, particularly women Care Setting Clinical research and diagnostics
Key Highlights
Development of scalable LC-MS pipelines for proteomics Addressing cellular heterogeneity in women's heart health Advancements in remote blood sampling for population studies Guideline-Based Recommendations
Diagnosis
Utilize individual omic signatures for clinically actionable diagnosis Management
Implement individualized therapies based on proteomic data Monitoring & Follow-up
Assess analytical performance at each step of the workflow Risks
Recognize the impact of pathological heterogeneity on health outcomes Patient & Prescribing Data
Women with cardiac diseases
Therapies should be tailored based on individual cellular heterogeneity
Clinical Best Practices
Standardize LC-MS workflows to ensure operational simplicity and robustness Incorporate QC measures in proteomic analyses Related Resources & Content
